334 related articles for article (PubMed ID: 15170353)
1. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
[TBL] [Abstract][Full Text] [Related]
2. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
[TBL] [Abstract][Full Text] [Related]
3. Pathway complexity of prion protein assembly into amyloid.
Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
[TBL] [Abstract][Full Text] [Related]
4. Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.
Macedo B; Sant'Anna R; Navarro S; Cordeiro Y; Ventura S
Microb Cell Fact; 2015 Nov; 14():174. PubMed ID: 26536866
[TBL] [Abstract][Full Text] [Related]
5. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
6. Scrapie-infected cells, isolated prions, and recombinant prion protein: a comparative study.
Kneipp J; Miller LM; Spassov S; Sokolowski F; Lasch P; Beekes M; Naumann D
Biopolymers; 2004 May-Jun 5; 74(1-2):163-7. PubMed ID: 15137116
[TBL] [Abstract][Full Text] [Related]
7. Prion protein amyloid: separation of scrapie infectivity from PrP polymers.
Wille H; Baldwin MA; Cohen FE; DeArmond SJ; Prusiner SB
Ciba Found Symp; 1996; 199():181-99; discussion 199-201. PubMed ID: 8915611
[TBL] [Abstract][Full Text] [Related]
8. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
Ladner-Keay CL; Griffith BJ; Wishart DS
PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
[TBL] [Abstract][Full Text] [Related]
9. Separation of scrapie prion infectivity from PrP amyloid polymers.
Wille H; Zhang GF; Baldwin MA; Cohen FE; Prusiner SB
J Mol Biol; 1996 Jun; 259(4):608-21. PubMed ID: 8683568
[TBL] [Abstract][Full Text] [Related]
10. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
Wille H; Prusiner SB; Cohen FE
J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
[TBL] [Abstract][Full Text] [Related]
11. Distinct morphological and electrophysiological properties of an elk prion peptide.
Glaves JP; Gorski PA; Alier K; Ma L; Renault L; Primeau JO; Jhamandas JH; Young HS
Peptides; 2013 Feb; 40():49-56. PubMed ID: 23262353
[TBL] [Abstract][Full Text] [Related]
12. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
[TBL] [Abstract][Full Text] [Related]
13. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
14. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
15. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
16. Prion Protein Prolines 102 and 105 and the Surrounding Lysine Cluster Impede Amyloid Formation.
Kraus A; Anson KJ; Raymond LD; Martens C; Groveman BR; Dorward DW; Caughey B
J Biol Chem; 2015 Aug; 290(35):21510-22. PubMed ID: 26175152
[TBL] [Abstract][Full Text] [Related]
17. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
18. The Positively Charged Cluster in the N-terminal Disordered Region may Affect Prion Protein Misfolding: Cryo-EM Structure of Hamster PrP(23-144) Fibrils.
Lee CH; Saw JE; Chen EH; Wang CH; Uchihashi T; Chen RP
J Mol Biol; 2024 Jun; 436(11):168576. PubMed ID: 38641239
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
20. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]